The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Adverse events occuring after first application of study medication up to the test of cure visit for non-serious adverse events
Timeframe: Up to 30 days after end of treatment with study medication for serious adverse events